EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc.（EYPT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · EYPT · 截至 2026年6月8日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
9
近12个月
买卖比
0.11
Buy/Sell (by trades)
整体情绪
EyePoint Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
EYPT 季度内部人买卖趋势
EYPT 内幕交易卖出 · EYPT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · EYPT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
EYPT 高管卖出股份 · EYPT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 25, 2026 | Elston George CFO | Option | 7,500 | — | Form 4 |
| May 25, 2026 | Elston George CFO | Other | 3,627 | $47K | Form 4 |
| Apr 17, 2026 | Ribeiro Ramiro Chief Medical Officer | Option | 2,437 | $20K | Form 4 |
| Apr 17, 2026 | Ribeiro Ramiro Chief Medical Officer | Sale | 2,437 | $37K | Form 4 |
| Mar 23, 2026 | Duker Jay S. President and CEO · Director | Other | 76,766 | $1.01M⚡ | Form 4 |
| Mar 23, 2026 | Duker Jay S. President and CEO · Director | Other | 76,766 | $1.01M⚡ | Form 4 |
| Mar 16, 2026 | Duker Jay S. President and CEO · Director | Purchase | 1,500 | $20K | Form 4 |
| Mar 2, 2026 | Elston George CFO | Gift | 5,000 | — | Form 4 |
| Mar 2, 2026 | Elston George CFO | Gift | 5,000 | — | Form 4 |
| Mar 4, 2026 | Ribeiro Ramiro Chief Medical Officer | Option | 2,438 | $20K | Form 4 |
| Mar 4, 2026 | Ribeiro Ramiro Chief Medical Officer | Sale | 2,438 | $44K | Form 4 |
| Feb 17, 2026 | Ribeiro Ramiro Chief Medical Officer | Option | 2,437 | $20K | Form 4 |
| Feb 17, 2026 | Ribeiro Ramiro Chief Medical Officer | Sale | 2,437 | $37K | Form 4 |
| Jan 6, 2026 | Lurker Nancy Director | Option | 75,133 | — | Form 4 |
| Jan 6, 2026 | Duker Jay S. President and CEO · Director | Option | 20,793 | — | Form 4 |
| Jan 6, 2026 | Duker Jay S. President and CEO · Director | Other | 10,054 | $170K | Form 4 |
| Jan 6, 2026 | Elston George CFO | Option | 15,285 | — | Form 4 |
| Jan 6, 2026 | Elston George CFO | Other | 4,487 | $76K | Form 4 |
| Jan 5, 2026 | Ribeiro Ramiro Chief Medical Officer | Option | 29,250 | $242K | Form 4 |
| Jan 5, 2026 | Ribeiro Ramiro Chief Medical Officer | Sale | 42,544 | $727K | Form 4 |
| Jan 3, 2026 | Ribeiro Ramiro Chief Medical Officer | Option | 19,667 | — | Form 4 |
| Jan 3, 2026 | Ribeiro Ramiro Chief Medical Officer | Other | 6,373 | $111K | Form 4 |
| Jan 5, 2026 | Duker Jay S. President and CEO · Director | Option | 30,000 | — | Form 4 |
| Jan 3, 2026 | Duker Jay S. President and CEO · Director | Option | 65,000 | — | Form 4 |
| Jan 5, 2026 | Duker Jay S. President and CEO · Director | Other | 14,505 | $253K | Form 4 |
Duker Jay S.
President and CEO · Director
日期
Mar 23
股数
76,766
均价
$13.11
总金额
$1.01M ⚡
Duker Jay S.
President and CEO · Director
日期
Mar 23
股数
76,766
均价
$13.11
总金额
$1.01M ⚡
Duker Jay S.
President and CEO · Director
日期
Mar 16
股数
1,500
均价
$13.15
总金额
$20K
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 EYPT 内幕交易
EYPT 内幕交易
EyePoint Pharmaceuticals, Inc.（EYPT）内幕交易数据来源于公司内部人（包括Elston George (CFO), Duker Jay S. (President and CEO · Director), Ribeiro Ramiro (Chief Medical Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。EYPT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看EyePoint Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
EYPT 内幕交易 · 5个问题EyePoint Pharmaceuticals, Inc.（EYPT）的内部人包括高管和董事，如Elston George (CFO), Duker Jay S. (President and CEO · Director), Ribeiro Ramiro (Chief Medical Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026